82 filings
8-K/A
AVRO
AvroBio Inc
18 Jun 24
Other Events
11:51am
8-K
AVRO
AvroBio Inc
14 Jun 24
Other Events
4:30pm
8-K
AVRO
AvroBio Inc
11 Jun 24
Submission of Matters to a Vote of Security Holders
4:29pm
8-K
AVRO
AvroBio Inc
4 Jun 24
Other Events
9:30am
8-K
AVRO
AvroBio Inc
30 Jan 24
Regulation FD Disclosure
4:05pm
8-K
5vnrlpqdqblk 2v6t
30 Jan 24
AVROBIO and Tectonic Therapeutic Announce Merger
8:39am
8-K
wq4ovcw h1ap5br
12 Jul 23
AVROBIO to Explore Strategic Alternatives
7:13am
8-K/A
hf47r6ism esj
14 Jun 23
Cost Associated with Exit or Disposal Activities
5:19pm
8-K
5j3wy6wyzkn9ky
13 Jun 23
Other Events
4:41pm
8-K
k6yo377rg8 rkg
12 Jun 23
Termination of a Material Definitive Agreement
7:19am
8-K
gbzzd o107t7e01ksi
9 Jun 23
Departure of Directors or Certain Officers
4:11pm
8-K
62ngec69u 5fqz1
22 May 23
AVROBIO Announces Agreement to Sell Cystinosis Gene Therapy Program for $87.5 Million
7:04am
8-K
a595e2m0m8
18 May 23
AVROBIO Announces Positive Data from Phase 1/2 Clinical Trial of
7:11am
8-K
j7c3nl7hlp07
11 May 23
AVROBIO Reports First Quarter 2023 Financial Results and Provides Business Update
7:20am
8-K
do544z7 03s76
1 May 23
AVROBIO Announces Leadership Transition
7:40am
8-K
tlcs6
23 Mar 23
AVROBIO Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Update
7:11am
8-K
emvf2gcer
27 Feb 23
Other Events
4:39pm
8-K
gdulnf
7 Dec 22
Regulation FD Disclosure
7:37am
8-K
11hccb7y 54rpmub0uw
8 Nov 22
AVROBIO Reports Third Quarter 2022 Financial Results and Provides Business Update
7:15am
8-K
vryq64m2ws6dky68mr
7 Oct 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:26pm